We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $625M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.88%
AUM
$300M
AUM Growth
+$81.3M
Cap. Flow
+$53.7M
Cap. Flow %
17.92%
Top 10 Hldgs %
30.67%
Holding
195
New
35
Increased
77
Reduced
34
Closed
15

Top Buys

Rank Stock Value
1
ARKG icon
ARK Genomic Revolution ETF
ARKG
+$7.21M
2
TME icon
Tencent Music
TME
+$6.16M
3
MMYT icon
MakeMyTrip
MMYT
+$5.61M
4
ZTO icon
ZTO Express
ZTO
+$5.17M
5
HCAT icon
Health Catalyst
HCAT
+$3.76M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$5.96M
2
GLD icon
SPDR Gold Trust
GLD
+$1.3M
3
BSJK
Invesco BulletShares 2020 High Yield Corporate Bond ETF
BSJK
+$1.29M
4
IBDL
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
+$935K
5
CLX icon
Clorox
CLX
+$765K

Sector Composition

Rank Sector Weight
1 Technology 20.52%
2 Consumer Discretionary 15.83%
3 Healthcare 10%
4 Communication Services 9.83%
5 Consumer Staples 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
176
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
$201K 0.07%
1,770
-162
-8% -$17.7K
MO icon
177
Altria Group
MO
$125B
$200K 0.07%
+4,890
New +$196K
XLB icon
178
State Street Materials Select Sector SPDR ETF
XLB
$8.72B
$200K 0.07%
+5,520
New +$189K
UBS icon
179
UBS Group
UBS
$170B
$198K 0.07%
15,056
+1,279
+9% +$16.9K
ALL icon
180
Allstate
ALL
$70.6B
– –
-2,590
Closed -$244K
CLX icon
181
Clorox
CLX
$12B
– –
-3,642
Closed -$765K
EA icon
182
Electronic Arts
EA
$52.4B
– –
-2,876
Closed -$375K
EL icon
183
Estee Lauder
EL
$30.4B
– –
-2,196
Closed -$479K
EXPO icon
184
Exponent
EXPO
$3.19B
– –
-3,007
Closed -$217K
FEZ icon
185
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.29B
– –
-6,450
Closed -$234K
HYG icon
186
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
– –
-2,423
Closed -$203K
IAU icon
187
iShares Gold Trust
IAU
$62.8B
– –
-7,450
Closed -$268K
IBB icon
188
iShares Biotechnology ETF
IBB
$9.45B
– –
-44,039
Closed -$5.96M
IOVA icon
189
Iovance Biotherapeutics
IOVA
$2.04B
– –
-6,928
Closed -$228K
MRSN
190
DELISTED
Mersana Therapeutics
MRSN
– –
-465
Closed -$217K
QLYS icon
191
Qualys
QLYS
$4.76B
– –
-7,471
Closed -$732K
WFC icon
192
Wells Fargo
WFC
$254B
– –
-8,519
Closed -$200K
IBDL
193
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
– –
-37,061
Closed -$935K
BSJK
194
DELISTED
Invesco BulletShares 2020 High Yield Corporate Bond ETF
BSJK
– –
-55,365
Closed -$1.29M
4 5 6 7
8

Similar funds

SGA
Strategic Global Advisors Newport Beach, California $625M AUM 28.76% 1-Year Est. Return
DCA
DSG Capital Advisors Edina, Minnesota $625M AUM 30.33% 1-Year Est. Return
SIM
Sprucegrove Investment Management Toronto, Ontario, Canada $625M AUM 21.08% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $626M AUM 17.68% 1-Year Est. Return
AGWCA
Annis Gardner Whiting Capital Advisors Tampa, Florida $625M AUM 23.8% 1-Year Est. Return
MWP
Madison Wealth Partners Madison, Wisconsin $627M AUM 17.95% 1-Year Est. Return
KCG
Kinsale Capital Group Richmond, Virginia $624M AUM 15.35% 1-Year Est. Return
WVUF
West Virginia University Foundation Morgantown, West Virginia $623M AUM 16.48% 1-Year Est. Return

Bellecapital's Q4 2020 Portfolio in Review

As of Q4 2020, Bellecapital held 195 positions worth $300M, up 37% from $219M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellecapital deployed $53.7M of net new capital in Q4 2020, opening 35 new positions and adding to 77 existing holdings. Its largest new stake was ARK Genomic Revolution ETF: 90,517 shares worth $8.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was SPDR Gold Trust, an estimated $1.3M trimmed.

  • Bellecapital's largest Q4 2020 buy was ARK Genomic Revolution ETF: 90,517 shares worth $8.44M.
  • Bellecapital added most to ZTO Express in Q4 2020, an estimated $5.17M increase.
  • Bellecapital's biggest Q4 2020 reduction was SPDR Gold Trust, cutting an estimated $1.3M.
  • Bellecapital fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $5.96M.
  • Bellecapital's ten largest holdings make up 31% of its $300M portfolio in Q4 2020.
  • Bellecapital opened 35 new positions and closed 15 in Q4 2020.
  • Bellecapital's portfolio value rose 37% quarter-over-quarter to $300M.

Based on Bellecapital's 13F filing for Q4 2020, filed 14 Jan 2021.